Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) infection in men receiving treatment for HIV-1 infection

J Acquir Immune Defic Syndr. 1999 Dec 1;22(4):333-40. doi: 10.1097/00126334-199912010-00003.

Abstract

Objective: To determine the prevalence of human herpesvirus 8 (HHV-8) infection in men treated for HIV-1 infection in Denver, Colorado.

Design: Cross-sectional analysis

Methods: Blood samples were obtained from 216 HIV-1-infected men. Antibody to latency-associated nuclear antigen (LANA) was detected by an immunofluorescent assay and the presence of HHV-8 in peripheral blood mononuclear cells (PBMC) was detected by polymerase chain reaction amplification.

Results: Among HIV-1-infected men who did not have Kaposi's sarcoma (KS), prevalence of HHV-8 infection was 46% (95% confidence interval [CI], 0.39-0.52). LANA seropositivity was common both among subjects with KS and subjects without KS (69% versus 42%; p = .06), but detection of HHV-8 DNA in peripheral blood was strongly associated with a diagnosis of KS (44% versus 10%; p = .001). In a univariate analysis of study subjects without KS, neither the odds of LANA seropositivity nor detection of HHV-8 DNA in PBMC was significant for CD4+ lymphocyte count, HIV-1 virus load, the use of three drug antiretroviral regimens or the prior occurrence of non-KS AIDS-related conditions.

Conclusion: Although antibodies to HHV-8 are common among HIV-1-infected men, detection of HHV-8 DNA in PBMC is uncommon and is associated with a diagnosis of Kaposi's sarcoma.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AIDS-Related Opportunistic Infections / epidemiology*
  • AIDS-Related Opportunistic Infections / virology
  • Adult
  • Anti-HIV Agents / therapeutic use
  • Antibodies, Viral / blood
  • Antigens, Viral
  • Cross-Sectional Studies
  • DNA, Viral / blood
  • Fluorescent Antibody Technique
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV-1* / isolation & purification
  • Herpesviridae Infections / epidemiology*
  • Herpesviridae Infections / virology
  • Herpesvirus 8, Human / genetics
  • Herpesvirus 8, Human / immunology
  • Herpesvirus 8, Human / isolation & purification*
  • Humans
  • Male
  • Middle Aged
  • Nuclear Proteins / immunology
  • Polymerase Chain Reaction
  • Prevalence
  • Viral Load

Substances

  • Anti-HIV Agents
  • Antibodies, Viral
  • Antigens, Viral
  • DNA, Viral
  • Nuclear Proteins
  • latency-associated nuclear antigen